United States · 
Who invested in Actym Therapeutics, Inc.?
Actym Therapeutics, Inc.'s investors include Korea Investment Partners, Boehringer Ingelheim Venture Fund and Illumina Ventures.
United States · Series A startup
Who invested in Actym Therapeutics, Inc.
Funding summaryUpdated 26 Oct 2026
$26Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $26MOct 2023
- Investors
- 3
The rounds
- Oct 2023Series A$26M
Source recordedSEC filing: $11M sold, first sale Jun 2023
Founders and team
From the SEC filings it signed: 1 on the team.
- Christopher D ThanosExecutive Officer, Directori
On the board, as filediBenjamin D ChenJulie D CherringtonKanad D DasRon D Mazumder
Everyone who backed them
Boehringer Ingelheim Venture FundCorporate VC1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Actym Therapeutics, Inc.
How much has Actym Therapeutics, Inc. raised?
Actym Therapeutics, Inc. has raised $26M across 1 round since 2023.
When did Actym Therapeutics, Inc. last raise?
Actym Therapeutics, Inc.'s most recent round was a Series A of $26M in Oct 2023.
What was Actym Therapeutics, Inc.'s biggest round?
Its most recent round, $26M in Oct 2023, is also its largest on record.
Who backed Actym Therapeutics, Inc. first?
Actym Therapeutics, Inc.'s first round on record, in Oct 2023, was backed by Korea Investment Partners, Boehringer Ingelheim Venture Fund and Illumina Ventures.
What stage is Actym Therapeutics, Inc. at?
Actym Therapeutics, Inc.'s latest named round is a Series A, in Oct 2023.
Where is Actym Therapeutics, Inc. based?
Actym Therapeutics, Inc. is based in the United States.
Companies like Actym Therapeutics, Inc.
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.